MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.420
-0.020 (-1.39%)
At close: Jul 31, 2026, 4:00 PM EDT
1.430
+0.010 (0.70%)
After-hours: Jul 31, 2026, 7:34 PM EDT
MetaVia Employees
MetaVia had 8 employees as of December 31, 2025. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,640,625
Market Cap
7.33M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | -1 | -11.11% |
| Dec 31, 2024 | 9 | 1 | 12.50% |
| Dec 31, 2023 | 8 | 6 | 300.00% |
| Dec 31, 2022 | 2 | -3 | -60.00% |
| Dec 31, 2021 | 5 | -2 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bolt Biotherapeutics | 23 |
| Imunon | 20 |
| AEON Biopharma | 8 |
| CNS Pharmaceuticals | 8 |
| Aprea Therapeutics | 8 |
| Traws Pharma | 7 |
| Adial Pharmaceuticals | 5 |
| Can-Fite BioPharma | 5 |
MTVA News
- 23 days ago - MetaVia announces completion of dose titration in Phase 1 study of DA-1726 - TheFly
- 23 days ago - MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity - PRNewsWire
- 5 weeks ago - MetaVia Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 6 weeks ago - MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum - PRNewsWire
- 7 weeks ago - MetaVia Transcript: Emerging Growth Conference 93 - Transcripts
- 7 weeks ago - MetaVia Transcript: AGM 2026 - Transcripts
- 7 weeks ago - MetaVia presents data at ADA supporting DA-1726, vanoglipel - TheFly
- 7 weeks ago - MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential - PRNewsWire